A sampling of what's available...

US nuclear forces, 2013

By Hans M. Kristensen, Robert S. Norris
Prev 4 of 4 Next

Laura H. Kahn

The exodus of general medical physicians

The United States could better protect itself against epidemics and bioterrorism by supporting the people who will diagnose and treat the victims.

Bring back the Office of Technology Assessment

Without an effective advisory body such as OTA, Congress continues to make decisions about scientific and technological advancements it doesn't fully understand.

How the pet food scare affects global health

When a company decides to sell food on the international market (pet or otherwise), it better understand that everybody’s health is at stake.

Mother Nature’s bioterrorism

The alarming decline of honeybees and other species demonstrates that dangerous biothreats can originate from more natural, innocuous sources than Al Qaeda.

The evolution and consequences of synthetic biology

Synthetic biology could drastically alter our way of life. It's up to the scientific community to determine how.

Establishing a code of conduct in the life sciences

A Hippocratic oath is merely lip service, rigorous ethical standards need to be developed to properly vet those pursuing a career in the life sciences.

Animals: The world's best (and cheapest) biosensors

If health professionals want to identify an epidemic as early as possible, they need only look to their local zoo.

A dangerous biodefense path

The Bush administration claims its biological research initiative will help fight terrorism, but does this research violate the Biological Weapons Convention?

The security impact of the uninsured

How universal health care might prove to be an effective defense against bioterrorism.

Government oversight and the life sciences

Could increased U.S. regulation endanger research in the life sciences--á la human subject research?

Prev 4 of 4 Next

Profile

Laura H. Kahn (Profile Image)

Laura H. Kahn

A general internist who began her career in health care as a registered nurse, Kahn works on the research staff of Princeton University's Program on Science and Global Security. Her expertise is in public health, biodefense, and pandemics. From 2003-2005, she led a study that assessed the public health infrastructures of New Hampshire, New Jersey, New York, and Pennsylvania. She has also co-organized the Carnegie Corporation’s "Biodefense Challenge" seminar series, which introduces biosecurity, codes of conduct, and dual-use biotech threats to the life sciences community. Prior to joining Princeton, she was a managing physician for the New Jersey Department of Health and Senior Services and a medical officer for the Food and Drug Administration.

Columnist Resources

Recommended Links